Joe Jimenez

Joe Jimenez was CEO of Novartis from 2010 through 2018. Under his leadership, and driven by a commitment to R&D investment, Novartis developed one of the largest pipelines of self-originated drugs in the industry. Joe also transformed the company’s portfolio to focus on leading businesses with innovation power and global scale in pharmaceuticals, eye care, and generics.

Prior to serving as CEO of Novartis, Joe held the position of Division Head, at Novartis Pharmaceuticals. He joined Novartis in 2007 as Division Head, of Novartis Consumer Health. Previously, Joe served as President and CEO of the North American and European businesses for the H.J. Heinz Company. Additionally, he served on the Board of Directors of Colgate-Palmolive Co. from 2009 to 2015, and of AstraZeneca PLC from 2002 to 2007.